These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Ultrasound in radioembolization induced liver disease (REILD). Bohle W; Zoller WG Z Gastroenterol; 2015 Aug; 53(8):798-801. PubMed ID: 26284329 [TBL] [Abstract][Full Text] [Related]
28. Proton beam radiation as salvage therapy for bilateral colorectal liver metastases not amenable to second-stage hepatectomy. Colbert LE; Cloyd JM; Koay EJ; Crane CH; Vauthey JN Surgery; 2017 Jun; 161(6):1543-1548. PubMed ID: 28081954 [TBL] [Abstract][Full Text] [Related]
29. Safety and Efficacy of Radioembolization in Elderly (≥ 70 Years) and Younger Patients With Unresectable Liver-Dominant Colorectal Cancer. Kennedy AS; Ball DS; Cohen SJ; Cohn M; Coldwell D; Drooz A; Ehrenwald E; Kanani S; Rose SC; Nutting CW; Moeslein FM; Savin MA; Schirm S; Putnam SG; Sharma NK; Wang EA; Clin Colorectal Cancer; 2016 Jun; 15(2):141-151.e6. PubMed ID: 26541321 [TBL] [Abstract][Full Text] [Related]
30. [Radioembolization with (90)Y-microspheres for liver tumors]. Rodríguez-Fraile M; Iñarrairaegui M Rev Esp Med Nucl Imagen Mol; 2015; 34(4):244-57. PubMed ID: 25911062 [No Abstract] [Full Text] [Related]
31. Gastric Perforation Following Prophylactic Embolization of Right Gastric and Gastroduodenal Arteries Prior to Selective Internal Radiation Therapy. Shukla PA; Ahuja J; Kurli V; Patel RI; Kozuch PS Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1645-8. PubMed ID: 26071106 [TBL] [Abstract][Full Text] [Related]
32. Selective Internal Yttrium-90 Radioembolization Therapy (90Y-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy: Safety and Efficacy Cohort Study. Xing M; Prajapati HJ; Dhanasekaran R; Lawson DH; Kokabi N; Eaton BR; Kim HS Am J Clin Oncol; 2017 Feb; 40(1):27-34. PubMed ID: 25089529 [TBL] [Abstract][Full Text] [Related]
33. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Welsh JS; Kennedy AS; Thomadsen B Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S62-73. PubMed ID: 16979443 [TBL] [Abstract][Full Text] [Related]
34. Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases. Krishnan S; Lin EH; Gunn GB; Chandra A; Beddar AS; Briere TM; Das P; Delclos ME; Janjan NA; Crane CH Am J Clin Oncol; 2006 Dec; 29(6):562-7. PubMed ID: 17148992 [TBL] [Abstract][Full Text] [Related]
35. A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy. Lim L; Gibbs P; Yip D; Shapiro JD; Dowling R; Smith D; Little A; Bailey W; Liechtenstein M BMC Cancer; 2005 Oct; 5():132. PubMed ID: 16225697 [TBL] [Abstract][Full Text] [Related]
37. Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients. Stubbs RS; O'Brien I; Correia MM ANZ J Surg; 2006 Aug; 76(8):696-703. PubMed ID: 16916386 [TBL] [Abstract][Full Text] [Related]
38. The prognostic value of quantitative parameters of 18F-FDG PET/CT in the evaluation of response to internal radiation therapy with yttrium-90 in patients with liver metastases of colorectal cancer. Soydal C; Kucuk ON; Gecim EI; Bilgic S; Elhan AH Nucl Med Commun; 2013 May; 34(5):501-6. PubMed ID: 23478586 [TBL] [Abstract][Full Text] [Related]
39. Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study. Gibbs P; Gebski V; Van Buskirk M; Thurston K; Cade DN; Van Hazel GA; BMC Cancer; 2014 Dec; 14():897. PubMed ID: 25487708 [TBL] [Abstract][Full Text] [Related]
40. Dosimetric analysis of liver toxicity after liver metastasis stereotactic body radiation therapy. Barry A; McPartlin A; Lindsay P; Wang L; Brierley J; Kim J; Ringash J; Wong R; Dinniwell R; Craig T; Dawson LA Pract Radiat Oncol; 2017; 7(5):e331-e337. PubMed ID: 28442242 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]